By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Growth in its Life Sciences and Diagnostics segment helped Danaher's second-quarter sales expand 15 percent year over year, the company reported today.

Overall, sales increased to $3.71 billion for the three months ended July 1, compared to $3.22 billion a year ago, helped along by a 31 percent increase in its Life Sciences and Diagnostics business, which spiked to $704.8 million from $540.1 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.